Clinical trial
Ropinirole Controlled Release (CR) as an Adjunctive Agent in the Treatment of…
NCT00285727 · Stanford University, Other · Completed
Key facts
| NCT number | NCT00285727 |
|---|---|
| Title | Ropinirole Controlled Release (CR) as an Adjunctive Agent in the Treatment of Major Depression |
| Official title | Ropinirole Controlled Release (CR) as an Adjunctive Agent in the Treatment of Major Depression |
| Lead sponsor | Stanford University, Other |
| Collaborators | Duke University GlaxoSmithKline Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Depressive Disorder, Major |
| Intervention type | Drug |
| Interventions | Ropinirole CR |
| Enrollment | 60 |
| Start date | Jan 1, 2006 |
| Completion | Oct 1, 2007 |
| First posted | Feb 2, 2006 |
| Last update posted | May 19, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: